40 Xarelto Bleeding Lawsuits Confirmed For Bellwether Discovery Pool

Print

Xarelto Bleeding Lawsuits Contend The Anticoagulant Causes Blood Clots, Internal Bleeding, Gastrointestinal And Brain Hemorrhages That Can Lead To Death.

xarelto-bleeding-lawsuits-Wright-and-Schulte-LLCThe federal judge managing the multidistrict litigation for Xarelto bleeding lawsuits confirmed that 40 cases have been selected for the bellwether discovery pool. The Xarelto lawsuits allege plaintiffs suffered blood clots, bleeding in the brain, gastrointestinal bleeding, and fatal bleeding after taking the blood thinner. The complaints also contend Bayer HealthCare AG and Johnson & Johnson’s Janssen Pharmaceuticals Inc. unit, Xarelto’s maker and marketer, did not adequately warn of the bleeding risks associated with the anticoagulant medication. (In Re: Xarelto Products Liability Litigation, No. 2592)

Judge Eldon Fallon issued an order on March 7 listing the 40 Xarelto bleeding lawsuit claims that will go through the discovery process. The cases are representative of the 3,900 Xarelto complaints consolidated in the U.S. District Court, Eastern District of Louisiana for coordinated pretrial proceedings. Attorneys for plaintiffs and defendants filed a joint report to Judge Fallon on March 11 indicating that they were prepared to discuss the selected discovery pool cases during a case management conference on March 16. The parties were slated to discuss plaintiff and defendant fact sheets, preserving documents and electronically stored information, and other discovery issues, according to the joint report. (In Re: Xarelto Products Liability Litigation, No. 2592)

“The discovery process is a very important part in trial preparation because both parties discuss facts about the case, exchange documents, and take depositions of their witnesses,” says Wright & Schulte LLC, which continues to speak with men and women across the country who believe they have suffered serious bleeding side effects due to using Xarelto. If you have been injured after using Xarelto contact one of the the firm’s attorneys at Wright & Schulte LLC by calling 1-800-399-0795 or visit www.yourlegalhelp.com for more information.

Xarelto (rivaroxaban) is a blood thinner approved by the U.S. Food and Drug Administration (FDA) in July 2011 to reduce the risk of deep vein thrombosis and pulmonary embolism from occurring after hip or knee replacement surgery. Xarelto’s approval was expanded in November 2011 to reduce the risk of stroke in people with atrial fibrillation not caused by a heart valve problem. The blood thinner’s use was further expanded in November 2012 to treat deep vein thrombosis and pulmonary embolism.
[fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm326654.htm, FDA]

Bayer’s blockbuster drug is popular because the blood thinner does not require patients to have their blood monitored on a regular basis as does warfarin, a rival blood thinner marketed under the brand names, Coumadin and Jantoven. The two blood thinners have another difference, according to the FDA. Warfarin, which was approved more than 60 years ago, uses vitamin K as a reversal agent should internal bleeding occur whereas the new generation drug, Xarelto, does not have an approved reversal agent to counteract its anticoagulation effects.
[fda.gov/Drugs/NewsEvents/ucm405148.htm, FDA]

Court records indicate that Judge Fallon scheduled the first two Xarelto bellwether trials for February 6, 2017, and March 13, 2017, in the district court in New Orleans. The third trial is scheduled for April 24, 2017 in Mississippi and the fourth trial is set for May 30, 2017 in Texas, at federal district courts yet to be determined. Wright & Schulte explains that bellwether trials are considered test trials because they allow plaintiffs, defendants and the court to determine how a jury responds to facts and evidence presented during trial. The verdicts from bellwether trials will help the parties to predict the outcome of similar cases or determine whether to settle pending cases. (In re: Xarelto (Rivaroxaban) Products Liability Litigation, MDL 2592)

About Wright & Schulte and Filing A Xarelto Bleeding Lawsuit

Wright & Schulte LLC, an experienced personal injury firm, is dedicated to the belief that America’s legal system should work for the people. Every day, the attorneys of Wright & Schulte LLC stand up for the rights of people who have been injured or wronged and fight tirelessly to ensure that even the world’s most powerful corporations take responsibility for their actions. If you’re looking for a law firm that will guarantee the aggressive and personal representation you deserve, please do not hesitate to contact Wright & Schulte LLC today. Free Xarelto side effects lawsuit case evaluations are available through yourlegalhelp.com or by calling 1-800-399-0795.

Contact:
Wright & Schulte LLC
865 S. Dixie Dr.
Vandalia, Ohio 45377
1-800-399-0795
http://www.yourlegalhelp.com

This entry was posted in Wright & Schulte Lawsuit News. Bookmark the permalink.